Company: TELO
Filing Date: 2025-02-14
Form Type: S-3
Source: 0001493152-25-006943
Chunk: 54

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-3
Chunk 54
---
                                                                                                                                                               
 of Unit Agreement.*                                                                                                                                                |
| 5.1     |     | Opinion of Pearl Cohen Zedek Latzer Baratz LLP.**                                                                                                                  |
| 23.1    |     | Consent of Cherry Bekaert LLP.**                                                                                                                                   |
| 23.2    |     | Consent of Salberg & Company PA**                                                                                                                                  |
| 23.3    |     | Consent of Pearl Cohen Zedek Latzer Baratz LLP (contained in Exhibit 5.1).                                                                                         |
| 24.1    |     | Power of Attorney (included in the signature page)**                                                                                                               |
| 107     |     | Filing Fee Table.**                                                                                                                                                |

| *  | To                                                                                                                                 
 be filed, if necessary, by an amendment to the registration statement or incorporated by reference to a Current Report on Form 8-K 
 filed in connection with an underwritten offering of the shares offered hereunder.                                                 |
| ** | Filed                                                                                                                              
 herewith.                                                                                                                          |

| II-3 |

Item 17. Undertakings

(a) The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1